BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 17653092)

  • 21. Claudin-1 is a metastasis suppressor and correlates with clinical outcome in lung adenocarcinoma.
    Chao YC; Pan SH; Yang SC; Yu SL; Che TF; Lin CW; Tsai MS; Chang GC; Wu CH; Wu YY; Lee YC; Hong TM; Yang PC
    Am J Respir Crit Care Med; 2009 Jan; 179(2):123-33. PubMed ID: 18787218
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of CCL5 in invasion, proliferation and proportion of CD44+/CD24- phenotype of MCF-7 cells and correlation of CCL5 and CCR5 expression with breast cancer progression.
    Zhang Y; Yao F; Yao X; Yi C; Tan C; Wei L; Sun S
    Oncol Rep; 2009 Apr; 21(4):1113-21. PubMed ID: 19288016
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cancer cell CCL5 mediates bone marrow independent angiogenesis in breast cancer.
    Sax MJ; Gasch C; Athota VR; Freeman R; Rasighaemi P; Westcott DE; Day CJ; Nikolic I; Elsworth B; Wei M; Rogers K; Swarbrick A; Mittal V; Pouliot N; Mellick AS
    Oncotarget; 2016 Dec; 7(51):85437-85449. PubMed ID: 27863423
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CCL5/CCR5 axis promotes the motility of human oral cancer cells.
    Chuang JY; Yang WH; Chen HT; Huang CY; Tan TW; Lin YT; Hsu CJ; Fong YC; Tang CH
    J Cell Physiol; 2009 Aug; 220(2):418-26. PubMed ID: 19334035
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inflammation, genetic polymorphisms in proinflammatory genes TNF-A, RANTES, and CCR5, and risk of pancreatic adenocarcinoma.
    Duell EJ; Casella DP; Burk RD; Kelsey KT; Holly EA
    Cancer Epidemiol Biomarkers Prev; 2006 Apr; 15(4):726-31. PubMed ID: 16614115
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Functional expression of beta-chemokine receptors in osteoblasts: role of regulated upon activation, normal T cell expressed and secreted (RANTES) in osteoblasts and regulation of its secretion by osteoblasts and osteoclasts.
    Yano S; Mentaverri R; Kanuparthi D; Bandyopadhyay S; Rivera A; Brown EM; Chattopadhyay N
    Endocrinology; 2005 May; 146(5):2324-35. PubMed ID: 15718270
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The CCL5/CCR5 axis contributes to the perineural invasion of human salivary adenoid cystic carcinoma.
    Shen Z; Li T; Chen D; Jia S; Yang X; Liang L; Chai J; Cheng X; Yang X; Sun M
    Oncol Rep; 2014 Feb; 31(2):800-6. PubMed ID: 24337063
    [TBL] [Abstract][Full Text] [Related]  

  • 28. T-cell accumulation and regulated on activation, normal T cell expressed and secreted upregulation in adipose tissue in obesity.
    Wu H; Ghosh S; Perrard XD; Feng L; Garcia GE; Perrard JL; Sweeney JF; Peterson LE; Chan L; Smith CW; Ballantyne CM
    Circulation; 2007 Feb; 115(8):1029-38. PubMed ID: 17296858
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of HIV-1 replication by GB virus C infection through increases in RANTES, MIP-1alpha, MIP-1beta, and SDF-1.
    Xiang J; George SL; Wünschmann S; Chang Q; Klinzman D; Stapleton JT
    Lancet; 2004 Jun; 363(9426):2040-6. PubMed ID: 15207954
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Elevated expression of the CC chemokine regulated on activation, normal T cell expressed and secreted (RANTES) in advanced breast carcinoma.
    Luboshits G; Shina S; Kaplan O; Engelberg S; Nass D; Lifshitz-Mercer B; Chaitchik S; Keydar I; Ben-Baruch A
    Cancer Res; 1999 Sep; 59(18):4681-7. PubMed ID: 10493525
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The interplay between gastric cancer cell lines and PBMCs mediated by the CC chemokine RANTES plays an important role in tumor progression.
    Okita K; Furuhata T; Kimura Y; Kawakami M; Yamaguchi K; Tsuruma T; Zembutsu H; Hirata K
    J Exp Clin Cancer Res; 2005 Sep; 24(3):439-46. PubMed ID: 16270531
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The potential to target CCL5/CCR5 in breast cancer.
    Velasco-Velázquez M; Xolalpa W; Pestell RG
    Expert Opin Ther Targets; 2014 Nov; 18(11):1265-75. PubMed ID: 25256399
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glycosaminoglycans and their synthetic mimetics inhibit RANTES-induced migration and invasion of human hepatoma cells.
    Sutton A; Friand V; Papy-Garcia D; Dagouassat M; Martin L; Vassy R; Haddad O; Sainte-Catherine O; Kraemer M; Saffar L; Perret GY; Courty J; Gattegno L; Charnaux N
    Mol Cancer Ther; 2007 Nov; 6(11):2948-58. PubMed ID: 18025279
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CCR5 antagonist blocks metastasis of basal breast cancer cells.
    Velasco-Velázquez M; Jiao X; De La Fuente M; Pestell TG; Ertel A; Lisanti MP; Pestell RG
    Cancer Res; 2012 Aug; 72(15):3839-50. PubMed ID: 22637726
    [TBL] [Abstract][Full Text] [Related]  

  • 35. RANTES (CCL5) induces a CCR5-dependent accelerated shedding of syndecan-1 (CD138) and syndecan-4 from HeLa cells and forms complexes with the shed ectodomains of these proteoglycans as well as with those of CD44.
    Charnaux N; Brule S; Chaigneau T; Saffar L; Sutton A; Hamon M; Prost C; Lievre N; Vita C; Gattegno L
    Glycobiology; 2005 Feb; 15(2):119-30. PubMed ID: 15355933
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Histone modification in the TGFbetaRII gene promoter and its significance for responsiveness to HDAC inhibitor in lung cancer cell lines.
    Osada H; Tatematsu Y; Sugito N; Horio Y; Takahashi T
    Mol Carcinog; 2005 Dec; 44(4):233-41. PubMed ID: 16163707
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The CC chemokine RANTES in breast carcinoma progression: regulation of expression and potential mechanisms of promalignant activity.
    Azenshtein E; Luboshits G; Shina S; Neumark E; Shahbazian D; Weil M; Wigler N; Keydar I; Ben-Baruch A
    Cancer Res; 2002 Feb; 62(4):1093-102. PubMed ID: 11861388
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential expression of transforming growth factor beta receptors in human pancreatic adenocarcinoma.
    Venkatasubbarao K; Ahmed MM; Mohiuddin M; Swiderski C; Lee E; Gower WR; Salhab KF; McGrath P; Strodel W; Freeman JW
    Anticancer Res; 2000; 20(1A):43-51. PubMed ID: 10769633
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of RANTES- and aminooxypentane-RANTES-triggered desensitization signals reveals differences in recruitment of the G protein-coupled receptor complex.
    Vila-Coro AJ; Mellado M; Martín de Ana A; Martínez-A C; Rodríguez-Frade JM
    J Immunol; 1999 Sep; 163(6):3037-44. PubMed ID: 10477567
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Infiltrating CD8+ T cells in oral lichen planus predominantly express CCR5 and CXCR3 and carry respective chemokine ligands RANTES/CCL5 and IP-10/CXCL10 in their cytolytic granules: a potential self-recruiting mechanism.
    Iijima W; Ohtani H; Nakayama T; Sugawara Y; Sato E; Nagura H; Yoshie O; Sasano T
    Am J Pathol; 2003 Jul; 163(1):261-8. PubMed ID: 12819030
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.